Funded by the Wellcome Translational Partnership Award (TPA), the Medical Research Council Impact Accelerator Account (MRC IAA), and by the NIHR Manchester Biomedical Research Centre (BRC) this scheme enables researchers to access expertise to unlock translational bottlenecks.

Awards up to the value of £25k, for projects of 6-9 months in duration. Supports access to appropriate technical expertise required by a research group to unlock translational bottlenecks, for example bioinformaticians, statisticians, research nurses and/or clinicians time, regulatory advisors, entrepreneurs in residence or industrial secondments. The overall aim of the call is to facilitate progression of research projects along the translational pathway, unlocking bottlenecks, and bringing the University’s innovations closer to patient impact.

This scheme is now OPEN for applications. 

A2E awards will be funded through the Medical Research Council Impact Accelerator Account (MRC IAA 2022-25), the Wellcome TPA, and the NIHR Manchester BRC Next Generation Therapeutics theme. This scheme has a one-stage application process with a deadline on 12th December 2023. Other key dates for the A2E call are available below.

  • Funding call opens w/c 13th October 2023
  • RSMs costings deadline (if applicable) 10th November 2023
  • Application deadline 12 noon Tuesday 12th December 2023
  • Notification of outcomes w/c 26th February 2024
  • Projects start March 2024 onwards

Application brief and application form are available to download on this page after the call opens in October.

You can download and read the frequently asked questions for the Translation Manchester Accelerator Awards 2023 by following this link:

For more information on our activities and future funding opportunities subscribe to our newsletter. For any other queries please contact


Previous A2E awards

2024 Awards

Katie Finegan
Formulation optimisation and evaluation of a candidate ERK5 degrader for the treatment of cancer

Filippo Varese
Enhancing healthcare impact and patient benefit for trauma survivors with complex mental health problems using face-to-face and digitally assisted Eye-Movement Desensitisation and Reprocessing (EMDR) therapy

Lisa Riste
Supporting Digital Technology Assessment Criteria (DTAC) compliance enabling sight impairment case-finding integration within Pharmacy Software Systems

James Eales
Optimisation of a non-invasive RNA-based diagnostic for kidney fibrosis by deep learning

Stephanie Shoop-Worrall
Psoriatic arthritis across the lifecourse: a new data resource for classification and prediction of outcome

Conal Hayton
Investigating lymphocyte signatures of interstitial lung disease in patients with connective tissue diseases: a novel precision medicine approach

Michaela Griffin
Regulators of R loop-formation as therapeutic targets in recurrent glioblastoma

Sankari Nagarajan
Two hit approach – Using CRISPR screens to identify the key chromatin-related/epigenetic proteins in breast cancer metastasis

More details on these projects, including lay summaries can be found by following this link.

2023 Awards

Brian Bigger
Analysis of lentiviral vector integration sites in stem cell gene therapy for Sanfilippo disease type IIIB

Jennifer Peterson
Information Resource for Parents facing Periviable Delivery

Neil Roberts
Economic feasibility of gene therapy for early onset bladder disease

Paul Nutter
Hypoglycemia T1DM-NICE Accelerator

Richard Unwin
Generation of validated standards for accurate measurement of the complementome in clinical samples

Silke Brix
Creation of the ARRS23 Software to Allow the Routine Use of the Prediction Tool in Clinical Practice

More details on these projects, including lay summaries can be found by following this link.

2022 Awards

Simon Harper
HypoCheat Clinical Trial Accelerator

Ellen Poliakoff
ACTION-PD: Delivering personalised video interventions by app for Parkinson’s and beyond

Claudia Lindner
Developing a technical and regulatory strategy to implement automated radiographic assessment into the Cerebral Palsy Integrated Pathway programme.

Caroline Jay
ECG-X: Explainable automated ECG interpretation for Long QT Syndrome – route to market

Martin Baron
Synthetic lethal targeting of Notch-driven breast cancer

More details on these projects, including lay summaries can be found by following this link.

2021 Awards

Martin Fergie
Development of a commercialization strategy for hypothesized interaction distribution as a patient stratification biomarker in follicular lymphoma
6 months of consultancy for commercialisation, regulatory and Intellectual Property advice

Pauline Whelan
Securing medical device regulatory expertise for a digital health platform to support people with Cystic Fibrosis
6 months of consultancy for medical device regulatory advice

Samuel Jones
Identifying the commercialization pathway for broad- spectrum antiviral polymers
5 months of consultancy to develop commercialisation plan

Sarah Cartmell
Novel Tendon Repair – Gap Analysis in preparation for a first in man trial
3 months of consultancy for MHRA gap analysis and design of clinical trial protocols

Sean Knight
Resolving inflammation and clinical recovery from COVID-19
12 months research nurse time to faciitate sample collection

Silke Brix
Prediction Tools to personalise medicine in ANCA- associated vasculitis
8 months of biostatistical expertise

2020 awards

Adam Reid
ComplexWounds@Manchester – Biobank
12 months access to research nurse

Claudia Lindner
Establishing a data sharing platform between clinicians and researchers for studying children’s hip diseases
8 months access to IT and imaging expertise

James Eales
A non-invasive “liquid biopsy” for chronic kidney disease
6 months access to expertise in single cell sequencing

Matthew Gittins
Improving patient outcomes and experience – translating stroke research expertise to Vestibular Schwannoma
12 month access to biostatics expertise and clinician time

Patrick Hamilton
Antigen specific therapy for Autoimmune Membranous Nephropathy (AMN)
9 months access to technical experimental expertise within a commercial company

Samuel Jones
Identifying the pathway to the clinic for broad spectrum antiviral polymers
6 months access to clinical trial expertise

2019 awards

Silke Brix
Risk stratification and modified immunotherapy to reduce mortality in elderly patients with ANCA-associated glomerulonephritis
4 months access to statistical expertise

Govind Oliver
Technology enhanced care in cardiac arrest
8 months access to software development expertise and clinician time

Paul Bishop
In-silico prediction of potential for immunogenicity of AMD therapeutics
3 months access to in silico evaluation expertise

Anna Woollams
Using clinical imaging to optimise therapy for individuals with aphasia
9 months access to app development and delivery expertise

James Fildes
Developing an arterial leukocyte filter that mimics leukocyte adhesion
6 months access to external peptide synthesis expertise

Jordi Bella
Engineered recombinant collagens for tissue regeneration applications
9 months access to expertise in TPP development

Tony Day
Development of Link-TSG6 as a protein biological with disease-modifying and anti-inflammatory properties
5 months access to bioinformatics expertise

Emma Gowen
Developing a partnership between Autism@Manchester and GMMH NHS autism services
9 months access to clinician and research co-ordinator time

2018 awards

Kathryn Abel
mSootheBox: Developing a Digital Health Intervention for Self Harm Management for Children and Young People
9 months access to augmented reality expertise and funds to establish an expert Research User Group

Jordi Bella
Cost of goods model for the manufacture of engineered recombinant collagens for tissue regeneration applications
6 months access to expertise to develop a cost of goods model.

Jeremy Derrick
Stratification by Immuno-profiling of IgG in Rheumatoid Arthritis and Psoriasis Patients
3 months access to informatics expertise 

Tracy Hussell
Macrophage adaptation in the inflamed lung
12 months access to clinician time for clinical sample collection

Matthias Pierce
‘CAPRI’: Children and Adolescents with PaRental mental Illness: Understanding the ‘who’ and the ‘how’ of targeting interventions
9 months access to an expert health economist

Stephen Richardson
Development of an adipose stem cell-GDF6 regenerative therapy for intervertebral disc degeneration and back pain
9 months access to an expert health economist and expert Research User Group

Mark Travis
Determining a novel pathway that controls TGF-beta activation in the human immune system
3 months access to research nurse and clinician time for clinical sample collection


Read about other funding opportunities by following the links below.

Confidence for Translation (C4T)

Up to £75k for translational research projects

Translation for ECRs (T4E)

Up to £5k for translational early career researchers

Access to Tissue (A2T)

Up to £10k to purchase tissue samples from the TMRN biobanks

TMAA 2023

An overview of the Translation Manchester Accelerator Awards 2023 call